Mary Bussell, CEO at TriMar Strategies, shared a post on LinkedIn:
“Lung cancer remains the leading cause of cancer mortality worldwide, yet it continues to be systematically under-prioritized in global and national policy agendas. In our newly published article in the European Journal of Cancer, Bridging the Gap in Lung Cancer: A Comprehensive Global Strategy for Change, we set out the evidence base and policy rationale that underpin the Lung Cancer Consensus Statement.
Sustained political leadership, policy coherence, and alignment across sectors are urgently required across the full lung cancer continuum, and more broadly across the entire cancer continuum, from prevention and early detection to diagnosis, treatment, survivorship, and destigmatization. Lung cancer is positioned at the intersection of aging, equity, health system strengthening, and development, and highlights the significant economic and societal costs of continued inaction.
Drawing on global evidence and policy analysis, we argue that strengthening lung cancer policy is not solely a health imperative. It is integral to safeguarding populations, protecting productivity, and reinforcing the resilience of health systems in the face of demographic change, environmental pressures, and future shocks.
This work was developed to inform and ground the Lung Cancer Consensus Statement: Bridging the Gap in the Diagnosis and Management of Lung Cancer, helping to move lung cancer decisively onto national and global policy agendas where it belongs.
I extend my thanks to my co-authors: Kostas Syrigos, Humaid Al-Shamsi, Ola Khorshid, Roy Herbst, Sofia Agelaki, Natasha Leighl, Fred Hirsch, Heather Wakelee.
This work reflects TriMar Strategies’ role in translating evidence into policy-relevant insight, convening diverse stakeholders, and supporting decision-makers to move from consensus to coordinated action. It provides the strategic foundation for the Lung Cancer Consensus Statement and for elevating lung cancer on national and global policy agendas.
I am grateful for funding received by TriMar Strategies from Merck to help with global consensus-building efforts to support the Lung Cancer Consensus Statement. Alexander Roediger, Mike Hartevelt, Allona McCloy.”
Lung Cancer Europe shared Mary Bussell’s post, adding:
“Really important to see this work brought together in the European Journal of Cancer.
Many of the messages here will feel familiar to those of us working in lung cancer, because they reflect years of shared evidence and advocacy. Having that consolidated in the literature is such an important step for policy conversations.
Congratulations to Mary Bussell, PhD, Kostas Syrigos and colleagues.”
More from Mary Bussell.